Press Release Archive

Our Company October 01, 2018

Where will the next big idea in healthcare come from?
Johnson & Johnson is counting on nurses.

Where will the next big idea in healthcare come from?
Johnson & Johnson is counting on nurses.
Latest News September 27, 2018

Janssen Elects Not to Continue Agreement with Geron for Imetelstat

Janssen Elects Not to Continue Agreement with Geron for Imetelstat
Innovation September 27, 2018

Johnson & Johnson Announces New Collaboration to Advance Novel Vaccine for MERS

Johnson & Johnson Announces New Collaboration to Advance Novel Vaccine for MERS
Innovation September 26, 2018

DePuy Synthes Expands Spine Portfolio with Nerve Assessment Platform
Designed to Identify & Avoid Nerves During Spine Surgery

DePuy Synthes Expands Spine Portfolio with Nerve Assessment Platform
Designed to Identify & Avoid Nerves During Spine Surgery
Innovation September 24, 2018

Johnson & Johnson Announces 10-year Initiative to Help End Tuberculosis, the World’s #1 Infectious Killer

Johnson & Johnson Announces 10-year Initiative to Help End Tuberculosis, the World’s #1 Infectious Killer
Innovation September 24, 2018

ETHICON’S NOVEL SKIN CLOSURE SYSTEM LEADS TO HIGHER
PATIENT AND SURGEON SATISFACTION AFTER TOTAL KNEE REPLACEMENT

ETHICON’S NOVEL SKIN CLOSURE SYSTEM LEADS TO HIGHER
PATIENT AND SURGEON SATISFACTION AFTER TOTAL KNEE REPLACEMENT
Innovation September 21, 2018

Janssen Announces Results of Esketamine Nasal Spray Phase 3 Study in Patients with Treatment-Resistant Depression

Janssen Announces Results of Esketamine Nasal Spray Phase 3 Study in Patients with Treatment-Resistant Depression
Innovation September 21, 2018

Johnson & Johnson Vision Showcases Latest Clinical Data and Eye Care Solutions at the ESCRS 2018 Annual Meeting

Johnson & Johnson Vision Showcases Latest Clinical Data and Eye Care Solutions at the ESCRS 2018 Annual Meeting
September 19, 2018

Johnson & Johnson to Host
Investor Conference Call on Third-Quarter Results

Johnson & Johnson to Host
Investor Conference Call on Third-Quarter Results
Innovation September 19, 2018

Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Erdafitinib for the Treatment of Metastatic Urothelial Cancer

Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Erdafitinib for the Treatment of Metastatic Urothelial Cancer

See More Press Releases